Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Antibody-drug-conjugate and its use for the treatment of cancer

Antibody-drug-conjugate and its use for the treatment of cancer

US Patent 10912841 · Granted Feb 9, 2021

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Sulfomaleimide-based linkers and corresponding conjugates2024
Antibody-drug-conjugate and its use for the treatment of cancer2024
Antibody-drug-conjugate and its use for the treatment of cancer2024
Antibody-drug-conjugate and its use for the treatment of cancer2024
IGF-1R antibody-drug-conjugate and its use for the treatment of cancer2023
IGF-1R antibody-drug-conjugate and its use for the treatment of cancer2023
IGF-1R antibody-drug-conjugate and its use for the treatment of cancer2023
Antibody-drug-conjugate and its use for the treatment of cancer2022
Antibody-drug-conjugate and its use for the treatment of cancer2022
Antibody-drug-conjugate and its use for the treatment of cancer2022
Antibody-drug-conjugate and its use for the treatment of cancer2022
Antibody-drug-conjugate and its use for the treatment of cancer2022